For: | Kartsoli S, Kostara CE, Tsimihodimos V, Bairaktari ET, Christodoulou DK. Lipidomics in non-alcoholic fatty liver disease. World J Hepatol 2020; 12(8): 436-450 [PMID: 32952872 DOI: 10.4254/wjh.v12.i8.436] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v12/i8/436.htm |
Number | Citing Articles |
1 |
Antonio Paride Passaro, Pierluigi Marzuillo, Stefano Guarino, Federica Scaglione, Emanuele Miraglia del Giudice, Anna Di Sessa. Omics era in type 2 diabetes: From childhood to adulthood. World Journal of Diabetes 2021; 12(12): 2027-2035 doi: 10.4239/wjd.v12.i12.2027
|
2 |
Yangzheng He, Yong Sun, Jing Li, Xiaoyu Peng, Wei Li, Yu Gao, Jiaqi Wang, Xinggang Ni, Lina Pan, Zeyuan Deng. Effects of Human Milk Fat Substitutes on Lipid Metabolism in First-Weaned Rats. Journal of Agricultural and Food Chemistry 2023; 71(37): 13906 doi: 10.1021/acs.jafc.3c02952
|
3 |
M. V. Kruchinina, M. F. Osipenko, A. A. Shestov, M. V. Parulikova. Fatty acid composition of blood serum and erythrocyte membranes in men with steatosis and steatohepatitis with normal transaminase activity. Sechenov Medical Journal 2024; 15(2): 48 doi: 10.47093/2218-7332.2024.15.2.48-60
|
4 |
Yan Li, Cuiyu Li, Yuhua Xiong, Bin Fang, Xing Lin, Quanfang Huang. Didymin Ameliorates Liver Fibrosis by Alleviating Endoplasmic Reticulum Stress and Glycerophospholipid Metabolism: Based on Transcriptomics and Metabolomics. Drug Design, Development and Therapy 2022; : 1713 doi: 10.2147/DDDT.S351092
|
5 |
Cuiyu Li, Bin Fang, Yuanyuan Wei, Rou Mo, Xing Lin, Quanfang Huang. The Regulatory Mechanism of <i>Smilax China</i> L. Saponins against Nonalcoholic Fatty Liver Is Revealed by Metabolomics and Transcriptomics. Journal of Oleo Science 2024; 73(5): 695 doi: 10.5650/jos.ess23167
|
6 |
Thit Mynster Kronborg, Qian Gao, Kajetan Trošt, Henriette Ytting, Malene Barfod O’Connell, Mikkel Parsberg Werge, Mira Thing, Lise Lotte Gluud, Ole Hamberg, Søren Møller, Thomas Moritz, Flemming Bendtsen, Nina Kimer. Low sphingolipid levels predict poor survival in patients with alcohol-related liver disease. JHEP Reports 2024; 6(2): 100953 doi: 10.1016/j.jhepr.2023.100953
|
7 |
Jyoti Gautam, Deepika Kumari, Hobby Aggarwal, Sonu Kumar Gupta, Siva Swapna Kasarla, Soumalya Sarkar, M.R. Kamla Priya, Parul Kamboj, Yashwant Kumar, Madhu Dikshit. Characterization of lipid signatures in the plasma and insulin-sensitive tissues of the C57BL/6J mice fed on obesogenic diets. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids 2023; 1868(9): 159348 doi: 10.1016/j.bbalip.2023.159348
|
8 |
Robert Ernst, Mike F. Renne, Aamna Jain, Alexander von der Malsburg. Endoplasmic Reticulum Membrane Homeostasis and the Unfolded Protein Response. Cold Spring Harbor Perspectives in Biology 2024; 16(8): a041400 doi: 10.1101/cshperspect.a041400
|
9 |
José Ignacio Martínez‐Montoro, María Ángeles Núñez‐Sánchez, María Antonia Martinez‐Sanchez, Andrés Balaguer‐Román, Virginia E. Fernández‐Ruiz, Mercedes Ferrer‐Gómez, Tomasz Sledzinski, María Dolores Frutos, José Carlos Fernández‐García, Adriana Mika, Bruno Ramos‐Molina. Hepatic and serum branched‐chain fatty acid profile in patients with nonalcoholic fatty liver disease: A case–control study. Obesity 2023; 31(4): 1064 doi: 10.1002/oby.23711
|
10 |
Helaina E. Huneault, Alasdair E. Gent, Catherine C. Cohen, Zhulin He, Zachery R. Jarrell, Rishikesan Kamaleswaran, Miriam B. Vos. Validation of a screening panel for pediatric metabolic dysfunction–associated steatotic liver disease using metabolomics. Hepatology Communications 2024; 8(3) doi: 10.1097/HC9.0000000000000375
|
11 |
Stanislav Veselskyi, Andrii Pototskyi, Viktor Tomchuk, Viktoriia Gryshchenko, Yevdokiia Reshetnik. Phospholipid composition of bile and blood in rats under correction of experimental fatty hepatosis. Ukrainian journal of veterinary sciences 2023; 14(3): 25 doi: 10.31548/veterinary3.2023.25
|
12 |
Josef Skoda, Klara Dohnalova, Karel Chalupsky, Aaron Stahl, Markus Templin, Jana Maixnerova, Stanislav Micuda, Lars Grøntved, Albert Braeuning, Petr Pavek. Off-target lipid metabolism disruption by the mouse constitutive androstane receptor ligand TCPOBOP in humanized mice. Biochemical Pharmacology 2022; 197: 114905 doi: 10.1016/j.bcp.2021.114905
|
13 |
Swapnil C. Kamble, Payel Ghosh. Defining omics-based biomarker signatures of metabolic dysfunction-associated steatotic liver disease (MASLD): In vitro studies. Current Opinion in Biomedical Engineering 2024; 30: 100534 doi: 10.1016/j.cobme.2024.100534
|
14 |
Laura Kalveram, Wolf-Hagen Schunck, Michael Rothe, Birgit Rudolph, Christoph Loddenkemper, Hermann-Georg Holzhütter, Stephan Henning, Philip Bufler, Marten Schulz, David Meierhofer, Ingrid W. Zhang, Karsten H. Weylandt, Susanna Wiegand, Christian A. Hudert. Regulation of the cytochrome P450 epoxyeicosanoid pathway is associated with distinct histologic features in pediatric non-alcoholic fatty liver disease. Prostaglandins, Leukotrienes and Essential Fatty Acids 2021; 164: 102229 doi: 10.1016/j.plefa.2020.102229
|
15 |
Annelie Falkevall, Annika Mehlem, Erika Folestad, Frank Chenfei Ning, Óscar Osorio-Conles, Rosa Radmann, Ana de Hollanda, Samuel D. Wright, Pierre Scotney, Andrew Nash, Ulf Eriksson. Inhibition of VEGF-B signaling prevents non-alcoholic fatty liver disease development by targeting lipolysis in the white adipose tissue. Journal of Hepatology 2023; 78(5): 901 doi: 10.1016/j.jhep.2023.01.014
|
16 |
Fengjiang Sun, Yichao Huang, Hexia Chen, Jialing Huang, Long Zhang, Shuchao Wei, Fangyi Liu, Da Chen, Wei Huang. BPA and its alternatives BPF and BPAF exaggerate hepatic lipid metabolism disorders in male mice fed a high fat diet. Science of The Total Environment 2023; 867: 161521 doi: 10.1016/j.scitotenv.2023.161521
|
17 |
Iván Rienda, Marta Moreno-Torres, Erika Moro, Judith Pérez-Rojas, Eugenia Pareja, Álvaro Pérez-Rubio, Nuria Peris, Jose Ángel Díez Ares, Ramón Trullenque, Ramiro Jover, Bernhard Lendl, Julia Kuligowski, Jose V. Castell, Guillermo Quintás. Assessing ATR-FTIR spectroscopy for steatosis quantification in liver biopsies in a long-duration cross-sectional study. Microchemical Journal 2024; 198: 110135 doi: 10.1016/j.microc.2024.110135
|
18 |
Denise Wolrab, Robert Jirásko, Ondřej Peterka, Jakub Idkowiak, Michaela Chocholoušková, Zuzana Vaňková, Karel Hořejší, Ivana Brabcová, David Vrána, Hana Študentová, Bohuslav Melichar, Michal Holčapek. Plasma lipidomic profiles of kidney, breast and prostate cancer patients differ from healthy controls. Scientific Reports 2021; 11(1) doi: 10.1038/s41598-021-99586-1
|
19 |
Nan Tang, Lei Ji, Xinyu Shi, Yalan Xiong, Xinying Xiong, Hanhua Zhao, Hualing Song, Jianying Wang, Lei Zhang, Shengfu You, Guang Ji, Baocheng Liu, Na Wu. Effects of Ganjianglingzhu Decoction on Lean Non-Alcoholic Fatty Liver Disease in Mice Based on Untargeted Metabolomics. Pharmaceuticals 2024; 17(4): 502 doi: 10.3390/ph17040502
|
20 |
Guogang Xu, Songhua Quan, Joseph Schell, Yucheng Gao, Mahboubeh Varmazyad, Prethish Sreenivas, Diego Cruz, Haiyan Jiang, Meixia Pan, Xianlin Han, Juan Pablo Palavicini, Peng Zhao, Xiaoli Sun, Erik D. Marchant, Blake B. Rasmussen, Guannan Li, Sakie Katsumura, Masahiro Morita, Erin Munkácsy, Nobuo Horikoshi, E. Sandra Chocron, David Gius. Mitochondrial ACSS1-K635 acetylation knock-in mice exhibit altered metabolism, cell senescence, and nonalcoholic fatty liver disease. Science Advances 2024; 10(20) doi: 10.1126/sciadv.adj5942
|
21 |
Yan Jiang, Qiming Gong, Yuanxun Gong, Chenyi Zhuo, Jinmei Huang, Qianli Tang. Vitexin Attenuates Non-alcoholic Fatty Liver Disease Lipid Accumulation in High Fat-Diet Fed Mice by Activating Autophagy and Reducing Endoplasmic Reticulum Stress in Liver. Biological and Pharmaceutical Bulletin 2022; 45(3): 260 doi: 10.1248/bpb.b21-00716
|
22 |
Nicole Haroun, Imene Bennour, Eva Seipelt, Julien Astier, Léa Sani, Catherine Tardivel, Ljubica Svilar, Jean‐Charles Martin, Lourdes Mounien, Jean François Landrier. Maternal Vitamin D Deficiency in Mice Sex‐Dependently Affects Hepatic Lipid Accumulation in Offspring. Molecular Nutrition & Food Research 2024; 68(1) doi: 10.1002/mnfr.202300290
|
23 |
Huaguo Chen, Lei Peng, Chao Zhao, Zongwei Cai, Xin Zhou. Protective Mechanism of Polygonum perfoliatum L. Extract on Chronic Alcoholic Liver Injury Based on UHPLC-QExactive Plus Mass Spectrometry Lipidomics and MALDI-TOF/TOF Mass Spectrometry Imaging. Foods 2022; 11(11): 1583 doi: 10.3390/foods11111583
|
24 |
An‐Qi Zhu, Nin Luo, Ling‐Yue Sun, Xiao‐Ting Zhou, Shi‐Sheng Chen, Zebo Huang, Xin‐Liang Mao, Kun‐Ping Li. Mulberry and Hippophae‐based solid beverage attenuate hyperlipidemia and hepatic steatosis via adipose tissue–liver axis. Food Science & Nutrition 2024; 12(7): 5052 doi: 10.1002/fsn3.4155
|
25 |
Helle Sedighi Frandsen, Joel Mario Vej-Nielsen, Lauren Elizabeth Smith, Lang Sun, Karoline Lindgaard Mikkelsen, Annemette Præstegaard Thulesen, Christina Erika Hagensen, Fuquan Yang, Adelina Rogowska-Wrzesinska. Mapping Proteome and Lipidome Changes in Early-Onset Non-Alcoholic Fatty Liver Disease Using Hepatic 3D Spheroids. Cells 2022; 11(20): 3216 doi: 10.3390/cells11203216
|
26 |
Thomai Mouskeftara, Georgios Kalopitas, Theodoros Liapikos, Konstantinos Arvanitakis, Georgios Germanidis, Helen Gika. Predicting Non-Alcoholic Steatohepatitis: A Lipidomics-Driven Machine Learning Approach. International Journal of Molecular Sciences 2024; 25(11): 5965 doi: 10.3390/ijms25115965
|
27 |
Zhendong Sun, Zhi Tang, Xiaoxi Yang, Qian S. Liu, Jianqing Zhang, Qunfang Zhou, Guibin Jiang. 3-tert-Butyl-4-hydroxyanisole Impairs Hepatic Lipid Metabolism in Male Mice Fed with a High-Fat Diet. Environmental Science & Technology 2022; 56(5): 3204 doi: 10.1021/acs.est.1c07182
|
28 |
Hua Tian, Presha Rajbhandari, Jay Tarolli, Aubrianna M. Decker, Taruna V. Neelakantan, Tina Angerer, Fereshteh Zandkarimi, Helen Remotti, Gilles Frache, Nicholas Winograd, Brent R. Stockwell. Multimodal mass spectrometry imaging identifies cell-type-specific metabolic and lipidomic variation in the mammalian liver. Developmental Cell 2024; 59(7): 869 doi: 10.1016/j.devcel.2024.01.025
|
29 |
Daniela Maria Tanase, Evelina Maria Gosav, Daniela Petrov, Alina Ecaterina Jucan, Cristina Mihaela Lacatusu, Mariana Floria, Claudia Cristina Tarniceriu, Claudia Florida Costea, Manuela Ciocoiu, Ciprian Rezus. Involvement of Ceramides in Non-Alcoholic Fatty Liver Disease (NAFLD) Atherosclerosis (ATS) Development: Mechanisms and Therapeutic Targets. Diagnostics 2021; 11(11): 2053 doi: 10.3390/diagnostics11112053
|
30 |
Achuthan Sourianarayanane, Christopher R. Brydges, Arthur J McCullough. Liver tissue lipids in metabolic dysfunction-associated steatotic liver disease with diabetes and obesity. Clinics and Research in Hepatology and Gastroenterology 2024; 48(7): 102402 doi: 10.1016/j.clinre.2024.102402
|
31 |
Gabriele Mocciaro, Michael Allison, Benjamin Jenkins, Vian Azzu, Isabel Huang-Doran, Luis Vicente Herrera-Marcos, Zoe Hall, Antonio Murgia, Davies Susan, Mattia Frontini, Antonio Vidal-Puig, Albert Koulman, Julian L. Griffin, Michele Vacca. Non-alcoholic fatty liver disease is characterised by a reduced polyunsaturated fatty acid transport via free fatty acids and high-density lipoproteins (HDL). Molecular Metabolism 2023; 73: 101728 doi: 10.1016/j.molmet.2023.101728
|
32 |
Wenxue Li, Mingxue Tan, Huiqi Wang, Ziwei Wang, Yaqin Pang, Rongfang Yang, Shiyuan Zhong, Xinhong Pan, Shen Chen, Qing Wang, Daochuan Li, Yongmei Xiao, Wen Chen, Liping Chen. METTL3-mediated m6A mRNA modification was involved in cadmium-induced liver injury. Environmental Pollution 2023; 331: 121887 doi: 10.1016/j.envpol.2023.121887
|
33 |
Ines L. Paraiso, Thai Q. Tran, Armando Alcazar Magana, Payel Kundu, Jaewoo Choi, Claudia S. Maier, Gerd Bobe, Jacob Raber, Chrissa Kioussi, Jan F. Stevens. Xanthohumol ameliorates Diet-Induced Liver Dysfunction via Farnesoid X Receptor-Dependent and Independent Signaling. Frontiers in Pharmacology 2021; 12 doi: 10.3389/fphar.2021.643857
|
34 |
Helena Castañé, Gerard Baiges-Gaya, Anna Hernández-Aguilera, Elisabet Rodríguez-Tomàs, Salvador Fernández-Arroyo, Pol Herrero, Antoni Delpino-Rius, Nuria Canela, Javier A. Menendez, Jordi Camps, Jorge Joven. Coupling Machine Learning and Lipidomics as a Tool to Investigate Metabolic Dysfunction-Associated Fatty Liver Disease. A General Overview. Biomolecules 2021; 11(3): 473 doi: 10.3390/biom11030473
|
35 |
Toni Radanović, Robert Ernst. The Unfolded Protein Response as a Guardian of the Secretory Pathway. Cells 2021; 10(11): 2965 doi: 10.3390/cells10112965
|
36 |
Helaina E. Huneault, Chih-Yu Chen, Catherine C. Cohen, Xueyun Liu, Zachery R. Jarrell, Zhulin He, Karla E. DeSantos, Jean A. Welsh, Kristal M. Maner-Smith, Eric A. Ortlund, Jeffrey B. Schwimmer, Miriam B. Vos. Lipidome Changes Associated with a Diet-Induced Reduction in Hepatic Fat among Adolescent Boys with Metabolic Dysfunction-Associated Steatotic Liver Disease. Metabolites 2024; 14(4): 191 doi: 10.3390/metabo14040191
|
37 |
Paraskevi Detopoulou, Tzortzis Nomikos, Elizabeth Fragopoulou, Smaragdi Antonopoulou. Association of PAF and its Metabolic Enzymes with GGT and the Fatty Liver Index in Healthy Volunteers. Current Vascular Pharmacology 2021; 19(6): 663 doi: 10.2174/1570161119666210628125239
|
38 |
Julia Kuligowski, Álvaro Pérez-Rubio, Marta Moreno-Torres, Polina Soluyanova, Judith Pérez-Rojas, Iván Rienda, David Pérez-Guaita, Eugenia Pareja, Ramón Trullenque-Juan, José V. Castell, Marcha Verheijen, Florian Caiment, Ramiro Jover, Guillermo Quintás. Cluster-Partial Least Squares (c-PLS) regression analysis: Application to miRNA and metabolomic data. Analytica Chimica Acta 2024; 1286: 342052 doi: 10.1016/j.aca.2023.342052
|
39 |
Min Zhou, Xiu Liu, Yongjun Wu, Qin Xiang, Rong Yu. Liver Lipidomics Analysis Revealed the Protective mechanism of Zuogui Jiangtang Qinggan Formula in type 2 diabetes mellitus with non-alcoholic fatty liver disease. Journal of Ethnopharmacology 2024; 329: 118160 doi: 10.1016/j.jep.2024.118160
|
40 |
Xiaxia Du, Yinuo Wang, Felix Kwame Amevor, Zifan Ning, Xun Deng, Youhao Wu, Shuo Wei, Xueqing Cao, Dan Xu, Yaofu Tian, Lin Ye, Gang Shu, Xiaoling Zhao. Effect of High Energy Low Protein Diet on Lipid Metabolism and Inflammation in the Liver and Abdominal Adipose Tissue of Laying Hens. Animals 2024; 14(8): 1199 doi: 10.3390/ani14081199
|
41 |
Qingfu Zhu, Hengrui Li, Zheng Ao, Hao Xu, Jiaxin luo, Connor Kaurich, Rui Yang, Pei-Wu Zhu, Sui-Dan Chen, Xiao-Dong Wang, Liang-Jie Tang, Gang Li, Ou-Yang Huang, Ming-Hua Zheng, Hui-Ping Li, Fei Liu. Lipidomic identification of urinary extracellular vesicles for non-alcoholic steatohepatitis diagnosis. Journal of Nanobiotechnology 2022; 20(1) doi: 10.1186/s12951-022-01540-4
|
42 |
Christina E. Kostara. Expanding the Molecular Disturbances of Lipoproteins in Cardiometabolic Diseases: Lessons from Lipidomics. Diagnostics 2023; 13(4): 721 doi: 10.3390/diagnostics13040721
|
43 |
Yixi Tao, Yanling Chen, Jie Ren, Shanwen Jiang, Siling Zhang, Hao Xu, Yun Li. Lipidomics and transcriptomics analysis revealed the role of the spleen of Nile tilapia (Oreochromis niloticus) in lipid metabolism. Aquaculture 2024; 592: 741173 doi: 10.1016/j.aquaculture.2024.741173
|
44 |
Xushan Yang, Linye Sun, Dongliang Feng, Yudi Deng, Wenzhen Liao. A lipidomic study: Nobiletin ameliorates hepatic steatosis through regulation of lipid alternation. The Journal of Nutritional Biochemistry 2023; 118: 109353 doi: 10.1016/j.jnutbio.2023.109353
|
45 |
Patcharamon Seubnooch, Matteo Montani, Sofia Tsouka, Emmanuelle Claude, Umara Rafiqi, Aurel Perren, Jean-Francois Dufour, Mojgan Masoodi. Characterisation of hepatic lipid signature distributed across the liver zonation using mass spectrometry imaging. JHEP Reports 2023; 5(6): 100725 doi: 10.1016/j.jhepr.2023.100725
|
46 |
Gino A. Kurian, Bhavana Sivakumar. Phospholipases in Physiology and Pathology. 2023; : 3 doi: 10.1016/B978-0-443-15177-4.00007-8
|
47 |
Chengyuan Sun, Yan Guo, Peixu Cong, Yuan Tian, Xiang Gao. Liver Lipidomics Analysis Revealed the Novel Ameliorative Mechanisms of L-Carnitine on High-Fat Diet-Induced NAFLD Mice. Nutrients 2023; 15(6): 1359 doi: 10.3390/nu15061359
|
48 |
Asmita Pant, Yue Chen, Annapurna Kuppa, Xiaomeng Du, Brian D. Halligan, Elizabeth K. Speliotes. Perturbation of TM6SF2 Expression Alters Lipid Metabolism in a Human Liver Cell Line. International Journal of Molecular Sciences 2021; 22(18): 9758 doi: 10.3390/ijms22189758
|
49 |
Olga Estévez-Vázquez, Raquel Benedé-Ubieto, Feifei Guo, Beatriz Gómez-Santos, Patricia Aspichueta, Johanna Reissing, Tony Bruns, Carlos Sanz-García, Svenja Sydor, Lars P. Bechmann, Eva Maranillo, José Ramón Sañudo, María Teresa Vázquez, Arantza Lamas-Paz, Laura Morán, Marina S. Mazariegos, Andreea Ciudin, Juan M. Pericàs, María Isabel Peligros, Javier Vaquero, Eduardo Martínez-Naves, Christian Liedtke, José R. Regueiro, Christian Trautwein, Rafael Bañares, Francisco Javier Cubero, Yulia A. Nevzorova. Fat: Quality, or Quantity? What Matters Most for the Progression of Metabolic Associated Fatty Liver Disease (MAFLD). Biomedicines 2021; 9(10): 1289 doi: 10.3390/biomedicines9101289
|
50 |
Hunter W. Korsmo, Isma’il Kadam, Aziza Reaz, Rachel Bretter, Anjana Saxena, Caroline H. Johnson, Jorge Matias Caviglia, Xinyin Jiang. Prenatal Choline Supplement in a Maternal Obesity Model Modulates Offspring Hepatic Lipidomes. Nutrients 2023; 15(4): 965 doi: 10.3390/nu15040965
|
51 |
Shizan Xu, Yajie Wang, Zhengyang Li, Qian Hua, Miao Jiang, Xiaoming Fan. LncRNA GAS5 Knockdown Mitigates Hepatic Lipid Accumulation via Regulating MiR-26a-5p/PDE4B to Activate cAMP/CREB Pathway. Frontiers in Endocrinology 2022; 13 doi: 10.3389/fendo.2022.889858
|
52 |
Giuseppe Della Pepa, Fabrizia Carli, Silvia Sabatini, Samantha Pezzica, Marco Russo, Marilena Vitale, Maria Masulli, Gabriele Riccardi, Angela A. Rivellese, Olga Vaccaro, Lutgarda Bozzetto, Amalia Gastaldelli. Clusters of adipose tissue dysfunction in adults with type 2 diabetes identify those with worse lipidomic profile despite similar glycaemic control. Diabetes/Metabolism Research and Reviews 2024; 40(4) doi: 10.1002/dmrr.3798
|
53 |
Anna Di Sessa, Simona Riccio, Emilia Pirozzi, Martina Verde, Antonio Paride Passaro, Giuseppina Rosaria Umano, Stefano Guarino, Emanuele Miraglia del Giudice, Pierluigi Marzuillo. Advances in paediatric nonalcoholic fatty liver disease: Role of lipidomics. World Journal of Gastroenterology 2021; 27(25): 3815-3824 doi: 10.3748/wjg.v27.i25.3815
|
54 |
Thomas Kralj, Raju Khatri, Kenneth R. Brouwer, Kim L. R. Brouwer, Darren J. Creek. Lipidomics profiles in hepatocytes from nonalcoholic steatohepatitis patients differ markedly from in vitro‐induced steatotic hepatocytes. FEBS Letters 2022; 596(11): 1445 doi: 10.1002/1873-3468.14318
|
55 |
Yunjiang Yu, Chaojie Hao, Mingdeng Xiang, Jinglin Tian, Hongxuan Kuang, Zhenchi Li. Potential obesogenic effects of TBBPA and its alternatives TBBPS and TCBPA revealed by metabolic perturbations in human hepatoma cells. Science of The Total Environment 2022; 832: 154847 doi: 10.1016/j.scitotenv.2022.154847
|
56 |
Ambrin Farizah Babu, Saana Palomurto, Vesa Kärjä, Pirjo Käkelä, Marko Lehtonen, Kati Hanhineva, Jussi Pihlajamäki, Ville Männistö. Metabolic signatures of metabolic dysfunction-associated steatotic liver disease in severely obese patients. Digestive and Liver Disease 2024; doi: 10.1016/j.dld.2024.05.015
|
57 |
Zhihui Yu, Danrong Yu, Huichao Dang, Lixin Zhang, Xiaoyu Zhang, Shiyao Wang, Yisheng Chen. Whole Eggs Improve High-Fat Diet-Induced Disorders of the Hepatic Lipid Profile and Gut Microbiota in Mice. ACS Food Science & Technology 2022; 2(10): 1650 doi: 10.1021/acsfoodscitech.2c00240
|
58 |
Peng Xie, Jin-Bo Xie, Man-Yu Xiao, Mei Guo, Yan-Shuang Qi, Fang-Fang Li, Xiang-Lan Piao. Liver lipidomics analysis reveals the anti-obesity and lipid-lowering effects of gypnosides from heat-processed Gynostemma pentaphyllum in high-fat diet fed mice. Phytomedicine 2023; 115: 154834 doi: 10.1016/j.phymed.2023.154834
|
59 |
Sabina Cisa-Wieczorek, María Isabel Hernández-Alvarez. Deregulation of Lipid Homeostasis: A Fa(c)t in the Development of Metabolic Diseases. Cells 2020; 9(12): 2605 doi: 10.3390/cells9122605
|
60 |
Scott A. Willis, Stephen J. Bawden, Sundus Malaikah, Jack A. Sargeant, David J. Stensel, Guruprasad P. Aithal, James A. King. The role of hepatic lipid composition in obesity‐related metabolic disease. Liver International 2021; 41(12): 2819 doi: 10.1111/liv.15059
|
61 |
Ruina Zhai, Lei Feng, Yu Zhang, Wei Liu, Shengli Li, Zhiyong Hu. Combined Transcriptomic and Lipidomic Analysis Reveals Dysregulated Genes Expression and Lipid Metabolism Profiles in the Early Stage of Fatty Liver Disease in Rats. Frontiers in Nutrition 2021; 8 doi: 10.3389/fnut.2021.733197
|
62 |
Zhiyong He, Yangyang Bin, Guangshun Chen, Qiang Li, Wenling Fan, Yongqiang Ma, Junfang Yi, Xiaohua Luo, Zhi Tan, Jiequn Li. Identification of MAP3K4 as a novel regulation factor of hepatic lipid metabolism in non-alcoholic fatty liver disease. Journal of Translational Medicine 2022; 20(1) doi: 10.1186/s12967-022-03734-8
|
63 |
Lili Niu, Karolina Sulek, Catherine G. Vasilopoulou, Alberto Santos, Nicolai J. Wewer Albrechtsen, Simon Rasmussen, Florian Meier, Matthias Mann. Defining NASH from a Multi-Omics Systems Biology Perspective. Journal of Clinical Medicine 2021; 10(20): 4673 doi: 10.3390/jcm10204673
|
64 |
Xiaohong Sun, Yue Xi, Man Yan, Chang Sun, Jianjun Tang, Xueyun Dong, Zhengnan Yang, Liang Wu, Akira Sugawara. Lactiplantibacillus plantarum NKK20 Increases Intestinal Butyrate Production and Inhibits Type 2 Diabetic Kidney Injury through PI3K/Akt Pathway. Journal of Diabetes Research 2023; 2023: 1 doi: 10.1155/2023/8810106
|
65 |
Hüseyin Vural, Ferah Armutcu, Omer Akyol, Ralf Weiskirchen. The potential pathophysiological role of altered lipid metabolism and electronegative low-density lipoprotein (LDL) in non-alcoholic fatty liver disease and cardiovascular diseases. Clinica Chimica Acta 2021; 523: 374 doi: 10.1016/j.cca.2021.10.018
|
66 |
Eirini Martinou, Marinos Pericleous, Irena Stefanova, Vasha Kaur, Angeliki M. Angelidi. Diagnostic Modalities of Non-Alcoholic Fatty Liver Disease: From Biochemical Biomarkers to Multi-Omics Non-Invasive Approaches. Diagnostics 2022; 12(2): 407 doi: 10.3390/diagnostics12020407
|
67 |
Soo-Mi Kweon, Jose Irimia-Dominguez, Gayeoun Kim, Patrick T. Fueger, Kinji Asahina, Keith K. Lai, Daniela S. Allende, Quincy R. Lai, Chih-Hong Lou, Walter M. Tsark, Ju Dong Yang, Dominic S. Ng, Ju-Seog Lee, Patrick Tso, Wendong Huang, Keane K. Y. Lai. Heterozygous midnolin knockout attenuates severity of nonalcoholic fatty liver disease in mice fed a Western-style diet high in fat, cholesterol, and fructose. American Journal of Physiology-Gastrointestinal and Liver Physiology 2023; 325(2): G147 doi: 10.1152/ajpgi.00011.2023
|
68 |
Francisco C. Almeida, Kalicharan Patra, Andreas Giannisis, Anezka Niesnerova, Renu Nandakumar, Ewa Ellis, Tiago Gil Oliveira, Henrietta M. Nielsen. APOE genotype dictates lipidomic signatures in primary human hepatocytes. Journal of Lipid Research 2024; 65(2): 100498 doi: 10.1016/j.jlr.2024.100498
|
69 |
Simona Riccio, Rosa Melone, Caterina Vitulano, Pierfrancesco Guida, Ivan Maddaluno, Stefano Guarino, Pierluigi Marzuillo, Emanuele Miraglia del Giudice, Anna Di Sessa. Advances in pediatric non-alcoholic fatty liver disease: From genetics to lipidomics. World Journal of Clinical Pediatrics 2022; 11(3): 221-238 doi: 10.5409/wjcp.v11.i3.221
|
70 |
Ambrin Farizah Babu, Susanne Csader, Ville Männistö, Milla-Maria Tauriainen, Heikki Pentikäinen, Kai Savonen, Anton Klåvus, Ville Koistinen, Kati Hanhineva, Ursula Schwab. Effects of exercise on NAFLD using non-targeted metabolomics in adipose tissue, plasma, urine, and stool. Scientific Reports 2022; 12(1) doi: 10.1038/s41598-022-10481-9
|
71 |
Emanuel Passos, Cidália Pereira, Inês O. Gonçalves, Ana Faria, António Ascensão, Rosário Monteiro, José Magalhães, Maria J. Martins. Physical exercise positively modulates nonalcoholic steatohepatitis‐related hepatic endoplasmic reticulum stress. Journal of Cellular Biochemistry 2022; 123(10): 1647 doi: 10.1002/jcb.30250
|
72 |
Anastasios Semertzidis, Thomai Mouskeftara, Helen Gika, Petros Pousinis, Kali Makedou, Antonis Goulas, Jannis Kountouras, Stergios A. Polyzos. Effects of Combined Low-Dose Spironolactone Plus Vitamin E versus Vitamin E Monotherapy on Lipidomic Profile in Non-Alcoholic Fatty Liver Disease: A Post Hoc Analysis of a Randomized Controlled Trial. Journal of Clinical Medicine 2024; 13(13): 3798 doi: 10.3390/jcm13133798
|
73 |
Linlin Yao, Yuanyuan Wang, Jianbo Shi, Yanna Liu, Hao Guo, Xiaoxi Yang, Yaquan Liu, Junjie Ma, Danyang Li, Ziniu Wang, Zikang Li, Qian Luo, Jianjie Fu, Qinghua Zhang, Guangbo Qu, Yanxin Wang, Guibin Jiang. Toxicity of Tetrabromobisphenol A and Its Derivative in the Mouse Liver Following Oral Exposure at Environmentally Relevant Levels. Environmental Science & Technology 2021; 55(12): 8191 doi: 10.1021/acs.est.1c01726
|
74 |
Siyu Du, Xin Chen, Rumeng Ren, Li Li, Baohui Zhang, Qi Wang, Yan Meng, Zhenpeng Qiu, Guihong Wang, Guohua Zheng, Junjie Hu. Integration of network pharmacology, lipidomics, and transcriptomics analysis to reveal the mechanisms underlying the amelioration of AKT-induced nonalcoholic fatty liver disease by total flavonoids in vine tea. Food & Function 2024; 15(9): 5158 doi: 10.1039/D4FO00586D
|
75 |
Chunsheng Liu, Zihan Zhang, Boqun Li, Kai Huang, Yongkang Zhang, Meng Li, Robert J. Letcher. Lipid Metabolic Disorders Induced by Organophosphate Esters in Silver Carp from the Middle Reaches of the Yangtze River. Environmental Science & Technology 2024; 58(11): 4904 doi: 10.1021/acs.est.3c08610
|
76 |
Wenke Jonas, Kristin Schwerbel, Lisa Zellner, Markus Jähnert, Pascal Gottmann, Annette Schürmann. Alterations of Lipid Profile in Livers with Impaired Lipophagy. International Journal of Molecular Sciences 2022; 23(19): 11863 doi: 10.3390/ijms231911863
|